Evaluation of the fat-free mass index and its relationship with muscular dysmorphy in resistance training practitioners in the interior of Paraiba
Abstract
Introduction: The fat-free mass index (FFMI) has been suggested as a screening tool to identify the use of anabolic steroids (EAS) in resistance training practitioners. In addition, it has already been verified that individuals using EAS with MIFF >25kg/m2 have a higher prevalence of muscle dysmorphia (DISMUS). Objective: To verify the prevalence of EAS use and the association between FFMI levels and DISMUS symptoms in resistance training practitioners. Materials and methods: To verify the symptoms of muscle dysmorphia, the muscle satisfaction assessment scale (MASS) will be used, which has 19 questions with five scale levels for each answer. For anthropometric evaluation (weight, height and skinfolds) the values of body mass index (BMI), fat percentage (%G) and FFMI will be determined. Results and Discussion: The sample consisted of 38 subjects and it was found that only 10.5 were EAS users. It was verified that 63.20% of the individuals showed mild muscle dissatisfaction, 26.3% showed moderate muscle dissatisfaction and 10.5% showed severe muscle dissatisfaction. Individuals with moderate dissatisfaction correspond to the population at risk of suffering from DISMUS, while those with severe dissatisfaction are already possibly affected by this disorder. However, no association of any category of dissatisfaction with BMI, FFMI and %F was verified. Conclusion: Physical dissatisfaction was observed at different levels in this population. Our study highlights the importance of educational actions to raise awareness in a way to prevent problems that may further impair self-esteem and quality of life.
References
-Basaria, S. Androgen abuse in athletes: detection and consequences. The Journal of Clinical Endocrinology & Metabolism. Vol. 95. Num. 4. 2010. p. 1533-1543.
-Choi, P. Y. L.; Pope, H. G. Violence toward women and illicit androgenic-anabolic steroid use. Annals of Clinical Psychiatry. Vol. 6. Num. 1. 1994. p. 21-25.
-Daher, E. F. e colaboradores. Acute kidney injury due to anabolic steroid and vitamin supplement abuse: report of two cases and a literature review. International Urology and Nephrology. Num. 41. 2009. p. 717-723.
-Fineschi, V.; e colaboradores. Anabolic steroid abuse and cardiac sudden death: a pathologic study. Archives of pathology & laboratory medicine. Vol. 125. Num. 2. 2001. p. 253-255.
-González-Martí, I.; e colaboradores. Physical perceptions and self-concept in athletes with muscle dysmorphia symptoms. The Spanish journal of psychology. Vol. 17. 2014.
-Hartgens, F.; Kuipers, H. Effects of androgenicanabolic steroids in athletes. Sports Medicine. Vol. 38. 2004. p. 513-554.
-Hildebrandt, T. e colaboradores. Presence of muscle dysmorphia symptomology among male weightlifters. Comprehensive psychiatry. Vol. 47. Num. 2. 2006. p. 127-135.
-Iriart, J. A. B.; Chaves, J. C.; Orleans, R. G. Culto ao corpo e uso de anabolizantes entre praticantes de musculação. Caderno de Saúde Pública. Rio de Janeiro. vol. 25. Num. 4. 2009. p. 773-782.
-Jackson, A. S.; Pollock, M. L. Generalized equations for predicting body density of men. British journal of nutrition. Vol. 40. Num. 3. 1978. p. 497-504.
-Kanayama, G.; e colaboradores. Body image and attitudes toward male roles in anabolic-androgenic steroid users. American Journal of Psychiatry. Vol. 163. Num. 4. 2006. p. 697-703.
-Kleinman, C. C. Forensic issues arising from the use of anabolic steroids. Psychiatric Annals. Vol. 20. Num. 4. 1990. p. 219-221.
-Korkia, P.; Stimson, G. V. Indications of prevalence, practice and effects of anabolic steroid use in Great Britain. International journal of sports medicine. Vol. 18. Num. 07. 1997. p. 557-562.
-Kouri, E. M.; e colaboradores. Fat-free mass index in users and nonusers of anabolic-androgenic steroids. Clinical journal of sport medicine: official journal of the Canadian Academy of Sport Medicine. Vol. 5. Num. 4. 1995. p. 223-228.
-Lantz, C. D.; Rhea, D. J.; Cornelius, A. E. Muscle dysmorphia in elite-level power lifters and bodybuilders: a test of differences within a conceptual model. The Journal of Strength & Conditioning Research. Vol. 16. Num. 4. 2002. p. 649-655.
-Lise, M. L. Z.; e colaboradores. O abuso de esteróides anabólico-androgênicos em atletismo. Revista da Associação Médica Brasileira. Vol. 45. 1999. p. 364-370.
-Olivardia, R.; Pope, H. G.; Hudson, J. I. Muscle dysmorphia in male weightlifters: A case-control study. American Journal of Psychiatry. Vol. 157. Num. 8. 2000. p. 1291-1296.
-Pope, H. G.; Phillips, K. A.; Olivardia, R. O complexo de Adônis: a obsessão masculina pelo corpo. Rio de Janeiro: Campus. 2000. p. 94-96; 299-300.
-Rocha, M.; Aguiar, F.; Ramos, H. O uso de esteroides androgénicos anabolizantes e outros suplementos ergogénicos-uma epidemia silenciosa. Revista Portuguesa de Endocrinologia, Diabetes e Metabolismo. Vol. 9. Num. 2. 2014. p. 98-105.
-Saikali, C. J.; Soubhia, C. S.; Scalfaro, B. M.; Cordás, T. A. Imagem corporal nos transtornos alimentares. Revista de Psiquiatria Clínica USP. Vol. 31. Num. 4. 2004. p. 164-166.
-Silva-Junior, S. H. A.; Souza, M. A.; Silva, J. H. A. Tradução, adaptação e validação da escala de satisfação com a aparência muscular (MASS). Lecturas: Educacion Física y Desportes. 13. Revista Digital. 2008.
-Silva, P. R. P.; e colaboradores. Prevalência do uso de agentes anabólicos em praticantes de musculação de Porto Alegre. Arquivos brasileiros de endocrinologia & metabologia. Vol. 51. 2007. p. 104-110.
-Sociedade Brasileira de Endocrinologia e Metabologia. 10 coisas que você precisa saber sobre uso de anabolizantes. SBEM. 2021. Disponível em: https://www.endocrino.org.br/10-coisas-que-voce-precisa-saber-sobre-uso-de-anabolizantes-2/
-Wolke, D.; Sapouna, M. Big men feeling small: Childhood bullying experience, muscle dysmorphia and other mental health problems in bodybuilders. Psychology of Sport and Exercise. Vol. 9. Num. 5. 2008. p. 595-604.
Copyright (c) 2024 Ruy Suzuki Pinto Rabelo, Widemar Ferraz Silva
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish in this journal agree to the following terms:
- Authors retain the copyright and grant the journal the right of first publication, with work simultaneously licensed under the Creative Commons Attribution License BY-NC which allows the sharing of the work with acknowledgment of the authorship of the work and initial publication in this journal.
- Authors are authorized to enter into additional contracts separately for non-exclusive distribution of the version of the work published in this journal (eg, publishing in institutional repository or book chapter), with acknowledgment of authorship and initial publication in this journal.
- Authors are allowed and encouraged to post and distribute their work online (eg, in institutional repositories or on their personal page) at any point before or during the editorial process, as this can bring about productive change as well as increase impact and impact. citation of published work (See The Effect of Free Access).
